Oxidative stress measured by carbonyl groups level in postmenopausal women after oral and transdermal hormone therapy

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 9, 2012, Pages 1177-1181

  Polac, Ireneusz ^a   Borowiecka, Marta ^b   Wilamowska, Agnieszka ^a   Nowak, Pawel ^b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Hormone therapy; Menopause; Oxidative stress

Indexed keywords

2,4 DINITROPHENOL ANTIBODY; 2,4 DINITROPHENYLHYDRAZINE; ANTIBODY; CARBONYL DERIVATIVE; DYDROGESTERONE; ESTRADIOL; ESTROGEN; GESTAGEN; NORETHISTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONAL THERAPY; HUMAN; NORMAL HUMAN; OXIDATIVE STRESS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RISK REDUCTION; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE; PROGESTINS; PROTEIN CARBONYLATION;

EID: 84869167962     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01842.x     Document Type: Article

References (28)

1. Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220-1224.
2. Nowak P, Zbikowska HM, Ponczek M, Kolodziejczyk J, Wachowicz B. Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: Functional consequences. Thromb Res 2007; 121: 163-174. (Pubitemid 350138069)
3. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003; 329: 23-38. (Pubitemid 36187411)
4. Castelao JE, Gago-Dominguez M. Risk factors for cardiovascular disease in women: Relationship to lipid peroxidation and oxidative stress. Med Hypotheses 2008; 71: 39-44. (Pubitemid 351707592)
5. Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q. Long term estrogen plus progestogen therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2009; (2): 281.
6. Alamdari DH, Kostidou E, Paletas K et al. High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein. Free Radic Biol Med 2005; 39: 1362-1367. (Pubitemid 41540091)
7. Paton LN, Mocatta TJ, Richards AM, Winterbourn CC. Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction. Free Radic Biol Med 2010; 48: 223-229.
8. Cameron VA, Mocatta TJ, Pilbrow AP et al. Angiotensin type -1 recHTor A1166Cgene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension 2006; 47: 1155-1161. (Pubitemid 44289173)
9. Pantke U, Volk T, Schmutzler M, Kox WJ, Sitte N, Grune T. Oxidized proteins as a markerof oxidative stressduring coropnary heart surgery. Free Radic Biol Med 1999; 27: 1080-1086. (Pubitemid 29507480)
10. Himmelfarb J, McMonagle E, Freedman S et al. A Oxidative stress in increased in critically ill patients with acute renal failure. J Am Soc Nephrol 2004; 15: 2449-2456. (Pubitemid 39159345)
11. Winterbourn CC, Buss IH, Chan TP, Plank ID, Clark MA, Windsor JA. Protein carbonyl measurments show evidence of early oxidative stress in critically ill patients. Crit Care Med 2000; 28: 143-149. (Pubitemid 30091044)
12. Winterbourn CC, Bonham MJ, Buss H, Abu-Zidan FM, Windsor JA. Elevated protein carbonyls as plasma markers of oxidative stress in acute pancreatitis. Pancreatology 2003; 3: 375-382. (Pubitemid 37409865)
13. Baltacioglu E, Akalin FA, Alver A, Deger O, Karabulut E. Protein carbonyl levels in serum and gingival crevicular fluid in patients with chronic perodontitis. Arch Oral Biol 2008; 53: 716-722.
14. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002; 32: 797-803. (Pubitemid 34439250)
15. Aysegul T, Ufuk C, Akhan SE, Bilgin ME, Turfanda A, Sivas A. Postmenopausal hormone replacement therapy use decrreases oxidative protein damage. Gynecol Obstet Invest 2002; 54: 88-93. (Pubitemid 36164638)
16. Unfer TC, Conterato GMM, Silva JCN, Duarte MMMF, Emanuelli T. Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women. Cilinica Chimica Acta 2006; 396: 73-77. (Pubitemid 43783393)
17. Greendale GA, Lee NP, Arriola ER. The menoapuse. Lancet 1999; 353: 571-580.
18. Ayres S, Tang M, Subbiah R. Estradiol-17 beta as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants. J Lab Clin Med 1996; 128: 4.
19. Thibodeau PA, Kachadourian R, Lemay R, Bisson M, Day B, Paquette B. In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem 2002; 81: 227-236.
20. Bednarek-Tupikowska G, Tupikowski K, Bidzinka B. Serum lipid peroxides and total antioxidant ststus in postemenopausal women on hormone replacement therapy. Gynecol Endocrinol 2004; 19: 57-63. (Pubitemid 39331405)
21. Stetkiewicz T, Stachowiak G, Pakalski A, Makuła A, Surkont G, Pertyń ski T. Controversies on antioxidative effects of estrogens. Menopausal Review 2006; 6: 343-346. (Pubitemid 46188986)
22. Borras C, Gambini J, Gomez-Cabrera MC. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2 [MAPK]/NFkappaB cascade. Aging Cell 2005; 4: 113-118. (Pubitemid 41602744)
23. Shwaery GT, Vita JA, Keaney JF. Antioxidant protection of LDL by physiological concentrations of 17b-estradiol: Requirement for estradiol modification. Circulation 1997; 95: 1378.
24. Vihma V, Vehkavaara S, Yki-Jarvinen H, HoHTari H, Tikkanen MJ. Differential effects of oral and transdermal estradiol treatment on circulating estradiol fatty acid ester concentrations in posmenopausal women. J Clin Endocrinol Metab 2003; 88: 588.
25. Shimizu I. Impact of oestrogengs on the progession of liver disease. Liver Int 2003; 23: 63-69. (Pubitemid 37265776)
26. Tranquilli AL, Mazzanti L, Cugini AM, Cester N, Garzetti GG, Romanini C. Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. Gynecol Endocrinol 1995; 9: 137.
27. Signorelli SS, Neri S, Sciachitano S et al. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 2006; 53: 77-82. (Pubitemid 41736062)
28. Stetkiwicz T, Połłać I, Jedrzejczyk S, Stachowiak G, Pertyń ski T. Antioxidant activity of estrogens. Menopausal Review 2003; 2: 19-22.